The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
93515585 9351558 5 F 20120218 20160808 20130617 20160808 EXP JP-BRISTOL-MYERS SQUIBB COMPANY-19014653 BRISTOL MYERS SQUIBB SAKAMOTO M, ET AL.. REVIEW OF CASES IN WHICH ABATACEPT WERE USED IN OUR INSTITUTION AND AFFILIATED CLINICS.. THE 57TH ANNUAL GENERAL ASSEMBLY AND SCIENTIFIC MEETING OF THE JAPAN COLLEGE OF. 2013;504 68.00 YR M Y 75.00000 KG 20160808 OT JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
93515585 9351558 1 PS ORENCIA ABATACEPT 1 Intravenous (not otherwise specified) 7FEB12-IV DRIP INF, Y 125118 750 MG SOLUTION FOR INFUSION /month
93515585 9351558 2 SS CYCLOSPORIN CYCLOSPORINE 1 Oral 50 MG, BID Y 0 50 MG BID
93515585 9351558 3 SS PREDONINE PREDNISOLONEPREDNISOLONE ACETATEPREDNISOLONE SODIUM SUCCINATE 1 Oral 3MG Y 0 5 MG QD
93515585 9351558 4 SS PREDNISOLONE. PREDNISOLONE 1 Oral 3 MG, QD Y 0 3 MG QD
93515585 9351558 5 C THYRADIN S LEVOTHYROXINE SODIUM 1 Oral POW U 0 37.5 UG QD
93515585 9351558 6 C ALFACALCIDOL ALFACALCIDOL 1 Oral TAB U 0 .5 UG QD
93515585 9351558 7 C AMLODIPINE AMLODIPINE BESYLATE 1 Oral AMLODIPINE OD TABS U 0 5 MG QD
93515585 9351558 8 C LISINOPRIL. LISINOPRIL 1 Oral LISINOPRIL HYDRATE TABS U 0 10 MG QD
93515585 9351558 9 C NOVORAPID INSULIN ASPART 1 Subcutaneous 1 DF: 14-20-10 UNITS,INJ U 0 1 DF QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
93515585 9351558 1 Rheumatoid arthritis
93515585 9351558 2 Rheumatoid arthritis
93515585 9351558 3 Rheumatoid arthritis
93515585 9351558 4 Rheumatoid arthritis
93515585 9351558 5 Hypothyroidism
93515585 9351558 6 Osteoporosis
93515585 9351558 7 Hypertension
93515585 9351558 8 Hypertension
93515585 9351558 9 Diabetes mellitus

Outcome of event

Event ID CASEID OUTC COD
93515585 9351558 OT
93515585 9351558 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
93515585 9351558 Pleural infection bacterial
93515585 9351558 Pneumonia
93515585 9351558 Pneumothorax

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
93515585 9351558 1 20110725 20120207 0
93515585 9351558 2 200905 0
93515585 9351558 3 2009 0
93515585 9351558 4 2009 0
93515585 9351558 5 2004 0
93515585 9351558 6 2009 0
93515585 9351558 7 2004 0
93515585 9351558 8 2004 0
93515585 9351558 9 2010 0